Complete Bibliography

Over 100 peer-reviewed publications, abstracts, and scholarly works spanning four decades of advancing therapeutic apheresis medicine and preventative care.

Dr. Kiprov's research spans biological aging, Alzheimer's disease, autoimmune conditions, fertility, and the fundamental science of therapeutic apheresis. This page features his most significant peer-reviewed publications from a career spanning over 100 scholarly works. For a complete CV including all publications, abstracts, conference proceedings, and book chapters, please contact us below.

Showing 93 of 93 publications

1
Buck Institute partnership - placebo-controlled RCT

Multi-Omics Analysis Reveals Biomarkers That Contribute to Biological Age Rejuvenation in Response to Single-Blinded Randomized Placebo-Controlled Therapeutic Plasma Exchange

Fuentealba M, Kiprov D, Schneider K, Mu WC, Kumaar PA, Kasler H, Burton JB, Watson M, Halaweh H, King CD, Yuksel ZS, Roska-Pamaong C, Schilling B, Verdin E, Furman D

Aging Cell. 2025 Aug;24(8):e70103

A single-blinded, randomized, placebo-controlled study with the Buck Institute analyzing multi-omic biomarkers that contribute to biological age rejuvenation in response to therapeutic plasma exchange.

DOI: 10.1111/acel.70103
2
First proof TPE reduces biological age

Old Plasma Dilution Reduces Human Biological Age: A Clinical Study

Kim D, Kiprov DD, Luellen C, et al.

GeroScience 44, 2701-2720, 2022

The first clinical proof that therapeutic plasma exchange reduces human biological age by 1-3 years, measured using validated epigenetic clocks and biomarker panels.

DOI: 10.1007/s11357-022-00645-w
3

Attenuation of Age-Elevated Blood Factors by Repositioning Plasmapheresis: A Novel Perspective and Approach

Mehdipour M, Etienne J, Liu C, Mehdipour T, Kato C, Conboy M, Conboy I, Kiprov DD

Transfus Apher Sci. 2021 Jun;60(3):103162

Proposed a novel perspective on using plasmapheresis to attenuate age-elevated blood factors, repositioning an established clinical technique as an anti-aging intervention.

DOI: 10.1016/j.transci.2021.103162
4

Therapeutic Plasma Exchange (TPE) and Blood Products - Implications for Longevity and Disease

Kiprov D

Transfus Apher Sci. 2021 Jun;60(3):103163

Review of therapeutic plasma exchange and blood product implications for longevity, presenting the theoretical and clinical framework for TPE as a longevity intervention.

DOI: 10.1016/j.transci.2021.103163
5
Landmark parabiosis-to-human translation

Rejuvenation of Three Germ Layers Tissues by Exchanging Old Blood Plasma with Saline-Albumin

Mehdipour M, Skinner C, Wong N, Lieb M, Liu C, Etienne J, Kato C, Kiprov D, Conboy MJ, Conboy IM

Aging (Albany NY). 12, 8790-8819, 2020

Landmark parabiosis-to-human translation study proving that diluting and replacing old plasma with albumin rejuvenates tissues across multiple organ systems.

DOI: 10.18632/aging.103418
6
First hypothesis paper on TPE and aging

Intermittent Heterochronic Plasma Exchange as a Modality for Delaying Cellular Senescence - A Hypothesis

Kiprov D

J Clin Apheresis 28:387-389, 2013

The first hypothesis paper proposing that therapeutic plasma exchange could be used as an intervention for delaying cellular senescence and aging - predicting the research that would follow.

DOI: 10.1002/jca.21268

Complete Publication Record

Dr. Kiprov has authored or co-authored over 100 peer-reviewed publications, book chapters, abstracts, and review articles. For a complete CV including all publications, abstracts, presentations, and book chapters, please contact us.